Diagnostic and Therapeutic Inertia in LDL-C Management After Acute Myocardial Infarction
by dr. Kayla Audivisi
| 10 November 2026
Despite recommendations for intensive lipid-lowering therapy in patients following acute myocardial infarction (AMI), LDL-C target attainment remains suboptimal in clinical practice. Diagnostic and therapeutic inertia may contribute to persistent residual cardiovascular risk.